Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease

被引:90
|
作者
Morrow, David A. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
angina; atherosclerosis; myocardial infarction; prevention; prognosis; C-REACTIVE PROTEIN; ELEVATION MYOCARDIAL-INFARCTION; BRAIN NATRIURETIC PEPTIDE; ASSOCIATION TASK-FORCE; 2002 GUIDELINE UPDATE; PROGNOSTIC VALUE; FOLLOW-UP; SCIENTIFIC STATEMENT; DIABETIC-PATIENTS; AMERICAN-COLLEGE;
D O I
10.1161/CIRCULATIONAHA.109.852749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Risk assessment is essential to effective medical decision making for secondary prevention. A variety of clinical tools, including the most basic elements of the clinical history and the physical examination, provide valuable information on prognosis. In addition, data from the ECG, laboratory testing, and noninvasive and invasive imaging are complementary with respect to prognosis and can aid in informing patients and their families, directing triage, and guiding medical therapy. An integrated approach to risk assessment is optimal, and simple clinical risk scores can assist the clinician in assimilating the diverse sources of data on prognosis. Emerging tools for risk assessment continue to provide new insights into the pathogenesis of atherothrombosis and may advance the extent to which the promise of personalized preventive medicine can be realized in our routine care of patients with CV disease. Although discussed in the context of CHD, these principles are important to the full spectrum of patients with peripheral and cerebrovascular atherosclerotic disease. © 2010 American Heart Association, Inc.
引用
收藏
页码:2681 / 2691
页数:11
相关论文
共 50 条
  • [41] Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: Insights from the Heart and Soul Study
    Grenon, S. Marlene
    Vittinghoff, Eric
    Owens, Christopher D.
    Conte, Michael S.
    Whooley, Mary
    Cohen, Beth E.
    VASCULAR MEDICINE, 2013, 18 (04) : 176 - 184
  • [42] Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease
    Mehta, Puja K.
    Quesada, Odayme
    Al-Badri, Ahmed
    Fleg, Jerome L.
    Volgman, Annabelle Santos
    Pepine, Carl J.
    Merz, C. Noel Bairey
    Shaw, Leslee J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 348 : 1 - 8
  • [43] Resting heart rate in patients with stable coronary artery disease and diabetes: a report from the Euro Heart Survey on Diabetes and the Heart
    Anselmino, Matteo
    Ohrvik, John
    Ryden, Lars
    EUROPEAN HEART JOURNAL, 2010, 31 (24) : 3040 - 3045
  • [44] Coronary endothelial function testing provides superior discrimination compared with standard clinical risk scoring in prediction of cardiovascular events
    Reriani, Martin
    Sara, Jaskanwal D.
    Flammer, Andreas J.
    Gulati, Rajiv
    Li, Jing
    Rihal, Charanjit
    Lennon, Ryan
    Lerman, Lilach O.
    Lerman, Amir
    CORONARY ARTERY DISEASE, 2016, 27 (03) : 213 - 220
  • [45] Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul Study
    von Kaenel, Roland
    Carney, Robert M.
    Zhao, Shoujun
    Whooley, Mary A.
    CLINICAL RESEARCH IN CARDIOLOGY, 2011, 100 (03) : 241 - 247
  • [46] Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort
    Bae, Jae Hyun
    Moon, Min Kyong
    Oh, Sohee
    Koo, Bo Kyung
    Cho, Nam Han
    Lee, Moon-Kyu
    DIABETES & METABOLISM JOURNAL, 2020, 44 (03) : 458 - 469
  • [47] Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
    Wallentin, Lars
    Held, Claes
    Armstrong, Paul W.
    Cannon, Christopher P.
    Davies, Richard Y.
    Granger, Christopher B.
    Hagstrom, Emil
    Harrington, Robert A.
    Hochman, Judith S.
    Koenig, Wolfgang
    Krug-Gourley, Sue
    Mohler, Emile R., III
    Siegbahn, Agneta
    Tarka, Elizabeth
    Steg, Philippe Gabriel
    Stewart, Ralph A. H.
    Weiss, Robert
    Ostlund, Ollie
    White, Harvey D.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [48] Individual Coronary Heart Disease Risk Prediction as Part of Primary Prevention
    Berstein, L. L.
    Katamadze, N. O.
    Laznam, S. S.
    Grishkin, Y. N.
    KARDIOLOGIYA, 2012, 52 (10) : 65 - 74
  • [49] Serum total bilirubin levels and disease severity in patients with stable coronary artery disease
    Yu, J.
    Han, J. -L.
    Wang, G. -S.
    Guo, L. -J.
    Gao, W.
    HERZ, 2017, 42 (04) : 403 - 410
  • [50] Patients with a history of stable or unstable coronary heart disease have different acute phase responses to an inflammatory stimulus
    Werba, Jose Pablo
    Veglia, Fabrizio
    Amato, Mauro
    Baldassarre, Damiano
    Massironi, Paola
    Meroni, Pier Luigi
    Riboldi, Piersandro
    Tremoli, Elena
    Camera, Marina
    ATHEROSCLEROSIS, 2008, 196 (02) : 835 - 840